InsiderTrades

Form 4 for IT Gartner

Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001127602-25-014293 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-14 2025-05-12 IT Safian Craig EVP, CFO F - Tax $446.95 -3,562 81.3K -4% -$1.59M
D 2025-05-14 2025-05-12 IT Safian Craig EVP, CFO D - Sale to Iss $446.95 -3,680 84.9K -4% -$1.64M
D 2025-05-14 2025-05-12 IT Safian Craig EVP, CFO M - OptEx $154.31 +10.7K 88.5K +14% +$1.64M
D 2025-05-14 2025-05-13 IT Safian Craig EVP, CFO S - Sale+OE $450.17 -3,415 77.9K -4% -$1.54M
D 2025-05-14 2025-05-12 IT Safian Craig EVP, CFO M - OptEx $0.00 -10.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-12 F D 3,562 $446.95 81,305 D — — (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes.
2 Common Common Stock 2025-05-12 D D 3,680 $446.95 84,867 D — — (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.
3 Common Common Stock 2025-05-12 M A 10,657 $154.31 88,547 D — — (F1) Represents shares acquired upon exercise of SARs.
4 Common Common Stock 2025-05-13 S D 3,415 $450.17 77,890 D — — (F4) This transaction was executed in multiple trades at prices ranging from $449.88 to $450.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5 Derivative Stock Appreciation Rights 2025-05-12 M D 10,657 $0.00 0 D $154.31 · 2021-02-05 to 2027-02-05 10,657 Common Stock (F5) These SARs were part of an award that became exercisable in four substantially equal annual installments, commencing on February 5, 2021, and are fully exercisable.